SynthesisBMC cancer2015

Comparison of first-line chemotherapy based on irinotecan or other drugs to treat non-small cell lung cancer in stage IIIB/IV: a systematic review and meta-analysis.

Xue-Qin Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.